CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $1.97B, above the global median of $1.15B
- PositionCurrent ratio is 3.82×, higher than 95% of its Medical Care Facilities peers (median 1.22×)
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.02%
Annual Rate
CNY 0.34Paid semi-annual
Payout Ratio
56.4%Sustainable
Payback Period
61.7 yr
Last Ex-Dividend
Jul 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
13.30BCNY1.97B · vs all stocks (USD)
Trailing P/E
29.22xvs Medical Care Facilities peers
Revenue (TTM)
4.20BCNY623.22M · vs all stocks (USD)
Profit Margin
11.03%vs Medical Care Facilities peers
Beta
0.4840xvs all stocks
52-Week Change
-18.41%vs all stocks
Forward Annual Dividend Yield
2.02%vs all stocks
Market Capitalization
13.30BCNY1.97B · vs all stocks (USD)
Enterprise Value
10.75BCNY1.60B · vs all stocks (USD)
Trailing P/E
29.22xvs Medical Care Facilities peers
Forward P/E
22.63xvs Medical Care Facilities peers
PEG Ratio
2.63xvs Medical Care Facilities peers
Price to Sales (TTM)
3.22xvs Medical Care Facilities peers
Price to Book (MRQ)
2.46xvs Medical Care Facilities peers
Enterprise to Revenue
2.56xvs Medical Care Facilities peers
Enterprise to EBITDA
13.46xvs Medical Care Facilities peers
Gross Margin
46.13%vs Medical Care Facilities peers
Profit Margin
11.03%vs Medical Care Facilities peers
Operating Margin
20.21%vs Medical Care Facilities peers
Return on Assets (TTM)
5.01%vs Medical Care Facilities peers
Return on Equity (TTM)
7.68%vs Medical Care Facilities peers
Revenue (TTM)
4.20BCNY623.22M · vs all stocks (USD)
Revenue per Share (TTM)
5.01CNYUpdated Aug 20, 2026Quarterly Revenue Growth
5.20%vs Medical Care Facilities peers
Gross Profit (TTM)
1.82BCNY270.56M · vs all stocks (USD)
EBITDA (TTM)
658.27MCNY97.77M · vs all stocks (USD)
Net Income (TTM)
462.64MCNY68.71M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
14.70%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
943.26MCNY140.09M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
855.03MCNY126.99M · vs all stocks (USD)
Forward Annual Dividend Rate
0.3400CNYUpdated Aug 20, 2026Forward Annual Dividend Yield
2.02%vs all stocks
Trailing Annual Dividend Rate
0.2600CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.54%vs all stocks
Payout Ratio
56.36%vs Medical Care Facilities peers
Minority Interest (Equity)
182.28MCNYFY2025 · Dec 31, 2025Revenue
4.14BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.35BCNYFY2025 · Dec 31, 2025Gross Profit
1.79BCNYFY2025 · Dec 31, 2025Operating Income
637.96MCNY94.75M · vs all stocks (USD)
Pre-tax Income
573.81MCNYFY2025 · Dec 31, 2025Income Tax Expense
140.76MCNYFY2025 · Dec 31, 2025Net Income
433.06MCNYFY2025 · Dec 31, 2025EBIT
620.77MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
975.23MCNYFY2025 · Dec 31, 2025Research & Development
61.44MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
410.61MCNYFY2025 · Dec 31, 2025Other Operating Expenses
25.23MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
5.62MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
46.96MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.5300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.5300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
831.42MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
831.42MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
433.06MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
7.60MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
539.60MCNYFY2025 · Dec 31, 2025Free Cash Flow
311.42MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.49BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
433.06MCNYFY2025 · Dec 31, 2025Other Non-cash Items
115.96MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
19.66MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-29.07MCNYFY2025 · Dec 31, 2025Capital Expenditures
-228.18MCNYFY2025 · Dec 31, 2025Net Acquisitions
-301.15MCNYFY2025 · Dec 31, 2025Purchase of Investments
-108.42MCNYFY2025 · Dec 31, 2025Sale of Investments
161.52MCNYFY2025 · Dec 31, 2025Other Investing Activity
-600.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-1.08BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
60.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-274.68MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-260.98MCNYFY2025 · Dec 31, 2025Other Financing Charges
-242.86MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-718.52MCNYFY2025 · Dec 31, 2025Shares Outstanding
840.00MSharesUpdated Aug 20, 2026Float Shares
160.65MSharesUpdated Aug 20, 2026% Held by Insiders
79.98%vs all stocks
% Held by Institutions
3.27%vs all stocks
Total Cash (MRQ)
3.89BCNY578.41M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.68CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.08BCNY160.69M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1923xvs Medical Care Facilities peers
Current Ratio (MRQ)
3.82xvs Medical Care Facilities peers
Book Value per Share (MRQ)
6.54CNYUpdated Aug 20, 2026Total Assets
7.56BCNY1.12B · vs all stocks (USD)
Total Current Assets
4.37BCNYFY2025 · Dec 31, 2025Total Liabilities
2.10BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.18BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
965.75MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.14BCNYFY2025 · Dec 31, 2025Cash
2.51BCNYFY2025 · Dec 31, 2025Cash Equivalents
10.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.52BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.21BCNYFY2025 · Dec 31, 2025Accounts Receivable
318.45MCNYFY2025 · Dec 31, 2025Inventory
174.89MCNYFY2025 · Dec 31, 2025Accounts Payable
309.46MCNYFY2025 · Dec 31, 2025Short-term Debt
210.88MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.45MCNYFY2025 · Dec 31, 2025Long-term Debt
928.95MCNYFY2025 · Dec 31, 2025Common Stock (Book)
840.00MCNYFY2025 · Dec 31, 2025Retained Earnings
2.54BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.45BCNY809.86M · vs all stocks (USD)
Treasury Stock
201.02MCNYFY2025 · Dec 31, 202552-Week Low
14.46CNYUpdated Aug 20, 202652-Week High
22.95CNYUpdated Aug 20, 202652-Week Change
-18.41%vs all stocks
Beta
0.4840xvs all stocks
50-Day MA
15.90CNYUpdated Aug 20, 2026200-Day MA
17.60CNYUpdated Aug 20, 2026Avg 10-Day Volume
5.37MSharesUpdated Aug 20, 2026Avg 30-Day Volume
5.47MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.5500CNYUpdated Aug 20, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash Backing With Revenue And Income Streaks
Revenue has risen in each of three years, profit in all three, and it holds more cash than debt.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 3.82×, higher than 95% of its Medical Care Facilities peers (median 1.22×)Significant
Current ratio: 3.82Industry median: 1.22Industry P95: 3.59Peers compared: 32.00
Financial Health
Altman Z-Score 5.6: safe zoneNotable
Altman Z-Score: 5.60
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $1.97B, above the global median of $1.15BNotable
Market cap (USD): 1,974,900,144Global Median: 1,146,734,693.424
Revenue is $623.22M, above the global median of $520.53MNotable
Revenue (USD): 623,218,854.072Global Median: 520,528,949.311
Levered free cash flow is $126.99M, above the global median of $16.24MNotable
Levered free cash flow (USD): 126,989,219.566Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
SCG Packaging Public Company Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dai-Dan Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
GCS Holdings, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenyang Machine Tool Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Both Engineering Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
IJM Corporation Berhad
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Guangdong Skychem Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Sumec Corporation Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Jinko Power Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Pulse Biosciences Inc.
Tier 1ProductionThroughput-Bound ConversionRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Motomotion China Corp.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Largan Precision Co., Ltd.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Bosun Co., Ltd.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesCash Backing With Revenue And Income StreaksLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration